About MNG Laboratories
MNG Laboratories is a Healthcare company based in Atlanta (United States) founded in 2001, and was acquired by LabCorp in March 2019. Sequencing services for diagnostics and research are provided. Its chief executive, as recorded, is Terry Conrad. MNG Laboratories offers products and services including Whole Exome Sequencing, RNA Sequencing, and Whole Genome Sequencing. Its focus areas include Life Sciences, Genomics, Genomics Services and Sequencing. Its legal entity is Laboratory Corporation of America Holdings. Its competitors include Omniome, Rejuvenate Bio and Genewiz; 2 of its 3 listed competitors have raised funding.
Company details
MNG Laboratories was founded in 2001 in Atlanta, United States, within the biotechnology sector. Sequencing services are offered for diagnostics and research, encompassing RNA sequencing, MNG exome analysis, repeat expansion testing for Fragile X, and other clinical sequencing applications. Complex biochemical testing is also included in the portfolio, with operations focused on supporting medical and scientific needs.
Products & Services of MNG Laboratories
MNG Laboratories offers a comprehensive portfolio of products and services, including Whole Exome Sequencing, RNA Sequencing, and Whole Genome Sequencing.
Sequences exome to identify genetic variants for diagnosing disorders.
Analyzes RNA for additional genetic testing insights in disorders.
Provides full genome analysis for comprehensive disorder detection.
Apps and channels of MNG Laboratories
its YouTube channel LCA has 258 subscribers.
Funding Insights of MNG Laboratories
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of MNG Laboratories with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2015 | Series A | – | HealthEdge Investment Partners | – |
2 investors in total: 2 institutional.
Investors in MNG Laboratories
MNG Laboratories has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp and HealthEdge Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investing in healthcare businesses through private equity partnerships. | healthedgepartners.com | |||
Provider of laboratory tests for physicians | 1969 | labcorp.com | Burlington, United States |
Investor details for MNG Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MNG Laboratories
1 people are tracked at MNG Laboratories (1 in leadership).
| Name | Role | Group |
|---|---|---|
Terry Conrad | CEO & President | Leadership |
Complete people profiles for MNG Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of MNG Laboratories
3 dated milestones of MNG Laboratories across 18 years, from founding to its latest funding, stage changes and deals.
- Founded MNG Laboratories is founded.
- Funding First funding round.
- Exit Acquired by LabCorp.
Competitors of MNG Laboratories
MNG Laboratories has 3 listed competitors in our database, 2 of them funded. They include Omniome, Rejuvenate Bio and Genewiz.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| genewiz.com | 1999 | South Plainfield, United States | 452 | Genomic services are provided for the life sciences industry. |
Detailed competitors of MNG Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as MNG Laboratories (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mng Laboratories
Complete news archive for MNG Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MNG Laboratories
MNG Laboratories was founded in 2001 and raised its 1st funding round 14 years after it was founded.
MNG Laboratories is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Terry Conrad is the CEO of MNG Laboratories, as recorded in our data.
MNG Laboratories was founded in 2001 in Atlanta, United States, within the biotechnology sector. Sequencing services are offered for diagnostics and research, encompassing RNA sequencing, MNG exome analysis, repeat expansion testing for Fragile X, and other clinical sequencing applications. Complex biochemical testing is also included in the portfolio, with operations focused on supporting medical and scientific needs.
MNG Laboratories's top competitors include Omniome, Genewiz and Rejuvenate Bio.
MNG Laboratories offers Whole Exome Sequencing, RNA Sequencing, and Whole Genome Sequencing.
MNG Laboratories has 2 investors. Key investors include LabCorp, and HealthEdge Partners.
MNG Laboratories operates through Laboratory Corporation Of America Holdings.
Yes. MNG Laboratories was acquired by LabCorp in March 2019.